menu
    • menu

    Company profile for CollPlant

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block fo...
    CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, we are developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CollPlantIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    4 Oppenheimer Street P.O. Box 4132 Rehovot 7670104
    Telephone
    Telephone
    +972 73 2325600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://collplant.com/
    Linkedin
    Linkedin
    http://www.linkedin.com/company/collplant
    youtube
    YouTube
    Twitter
    Twitter
    http://x.com/CollplantBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Collplant Issues Letter To Shareholders
    Collplant Issues Letter To Shareholders

    13 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/collplant-issues-letter-to-shareholders-302740373.html

    PR NEWSWIRE
    13 Apr 2026
    Share Share
    Collplant Biotech Reveals 2025 Financials and Corporate Update
    Collplant Biotech Reveals 2025 Financials and Corporate Update

    26 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/collplant-biotechnologies-reports-2025-financial-results-and-provides-corporate-update-302726091.html

    PR NEWSWIRE
    26 Mar 2026
    Share Share
    Collplant Bio Gets Nasdaq Notice On Minimum Bid Rule
    Collplant Bio Gets Nasdaq Notice On Minimum Bid Rule

    24 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/collplant-biotechnologies-receives-nasdaq-notification-regarding-minimum-bid-requirement-302723716.html

    PR NEWSWIRE
    24 Mar 2026
    Share Share
    CollPlant to Report 2025 Full-Year Results on March 31
    CollPlant to Report 2025 Full-Year Results on March 31

    11 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-date-for-full-year-2025-financial-results-302710906.html

    PR NEWSWIRE
    11 Mar 2026
    Share Share
    CollPlant Secures Korean Patent for Photocurable Dermal Filler
    CollPlant Secures Korean Patent for Photocurable Dermal Filler

    26 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-korean-patent-allowance-secured-for-its-photocurable-dermal-filler-302698310.html

    PR NEWSWIRE
    26 Feb 2026
    Share Share
    Collplant Expands 3D Bioprinting Portfolio With Bioflex Launch
    Collplant Expands 3D Bioprinting Portfolio With Bioflex Launch

    23 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/collplant-elevates-rhcollagen-3d-bioprinting-portfolio-with-launch-of-ready-to-print-bioflex-302694478.html

    PR NEWSWIRE
    23 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search